Literature DB >> 24820766

Changes in prescribing patterns and clinical outcomes in elderly diabetic patients in 2000 and 2010: analysis of a large Italian population-based study.

Marta Baviera1, Laura Cortesi, Mauro Tettamanti, Fausto Avanzini, Giuseppe Marelli, Irene Marzona, Alessandro Nobili, Emma Riva, Ida Fortino, Angela Bortolotti, Luca Merlino, Maria Carla Roncaglioni.   

Abstract

PURPOSE: To describe prescribing patterns in elderly Italian diabetic patients of the Lombardy Region in 2000 and 2010 using an administrative database. Hospital admissions and mortality were also recorded and compared in the two index years.
METHODS: Analyses were performed on the whole cohort of elderly diabetic patients and across age groups. Direct age standardization was done, with data from the Lombardy Region database for 2005 used as reference to compare diabetic populations in the two index years. Logistic regression models were used to analyze changes in hospital admissions and mortality and to calculate odds ratios.
RESULTS: Using data retrieved from the Lombardy Region database we identified 176,384 and 283,982 elderly diabetic patients in 2000 and 2010, respectively. The overall rates of patients treated with antidiabetic drugs were 92.5% in 2000 and 97.0% in 2010. Between 2000 and 2010 the prescribing of glibenclamide declined by 30.0% (from 52.9 to 22.9%, p < 0.001) and that of biguanides rose by 17.4 % (from 47.5 to 64.8%, p < 0.001). In 2010 thiazolidinediones, dipeptidyl peptidase-4 inhibitors and incretin mimetic drugs were seldom prescribed. Drugs for cardiovascular prevention rose in all age classes from 2000 to 2010, and the rates of hospital admission overall fell from 32.0 to 26.8% (p < 0.001) during the same period, with the exception of those aged ≥85 years. Between 2000 and 2010 the mortality rate decreased in patients aged 65-74 years (from 3.4 to 2.9%, p < 0.0001) and rose significantly in those aged ≥85 years.
CONCLUSIONS: The drug prescription profile of elderly diabetic patients changed from 2000 to 2010, with a tendency toward recommended drugs. These changes may possibly be linked to the decrease in both hospital admissions and mortality in the diabetic group aged 65-74 years.

Entities:  

Mesh:

Year:  2014        PMID: 24820766     DOI: 10.1007/s00228-014-1678-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  42 in total

Review 1.  Evaluating the safety of diabetes drugs: perspective of a Food and Drug Administration insider.

Authors:  Robert I Misbin
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

2.  Standards of medical care in diabetes--2008.

Authors: 
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

3.  Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.

Authors:  Nihar R Desai; William H Shrank; Michael A Fischer; Jerry Avorn; Joshua N Liberman; Sebastian Schneeweiss; Juliana Pakes; Troyen A Brennan; Niteesh K Choudhry
Journal:  Am J Med       Date:  2012-03       Impact factor: 4.965

4.  Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000-2010.

Authors:  Carlotta Franchi; Mauro Tettamanti; Luca Pasina; Codjo Djade Djignefa; Ida Fortino; Angela Bortolotti; Luca Merlino; Alessandro Nobili
Journal:  Eur J Clin Pharmacol       Date:  2014-01-08       Impact factor: 2.953

5.  Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study.

Authors:  Sheldon Greenfield; John Billimek; Fabio Pellegrini; Monica Franciosi; Giorgia De Berardis; Antonio Nicolucci; Sherrie H Kaplan
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

6.  National diabetes programs. Application of capture-recapture to count diabetes?

Authors:  G Bruno; R E LaPorte; F Merletti; A Biggeri; D McCarty; G Pagano
Journal:  Diabetes Care       Date:  1994-06       Impact factor: 19.112

7.  Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Authors:  Philip D Home; Stuart J Pocock; Henning Beck-Nielsen; Paula S Curtis; Ramon Gomis; Markolf Hanefeld; Nigel P Jones; Michel Komajda; John J V McMurray
Journal:  Lancet       Date:  2009-06-06       Impact factor: 79.321

8.  Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus.

Authors:  Kristine Yaffe; Cherie M Falvey; Nathan Hamilton; Tamara B Harris; Eleanor M Simonsick; Elsa S Strotmeyer; Ronald I Shorr; Andrea Metti; Ann V Schwartz
Journal:  JAMA Intern Med       Date:  2013-07-22       Impact factor: 21.873

9.  Antidepressant drug use and future diabetes risk.

Authors:  M Kivimäki; G D Batty
Journal:  Diabetologia       Date:  2011-10-29       Impact factor: 10.122

10.  Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

Authors:  Michael Bodmer; Christian Meier; Stephan Krähenbühl; Susan S Jick; Christoph R Meier
Journal:  Diabetes Care       Date:  2008-09-09       Impact factor: 17.152

View more
  3 in total

1.  Antidiabetic and cardiovascular drug utilisation in patients diagnosed with type 2 diabetes mellitus over the age of 80 years: a population-based cohort study.

Authors:  Shota Hamada; Martin C Gulliford
Journal:  Age Ageing       Date:  2015-05-25       Impact factor: 10.668

2.  Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy.

Authors:  Valentina Orlando; Francesca Guerriero; Daria Putignano; Valeria M Monetti; Daniele U Tari; Giuseppin Farina; Maddalena Illario; Guido Iaccarino; Enrica Menditto
Journal:  Curr Diabetes Rev       Date:  2015

3.  Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas.

Authors:  Giuseppe Roberto; Francesco Barone-Adesi; Francesco Giorgianni; Valeria Pizzimenti; Carmen Ferrajolo; Michele Tari; Claudia Bartolini; Roberto Da Cas; Marina Maggini; Stefania Spila-Alegiani; Paolo Francesconi; Gianluca Trifirò; Elisabetta Poluzzi; Fabio Baccetti; Rosa Gini
Journal:  BMC Endocr Disord       Date:  2019-02-07       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.